Skip to main content

Advertisement

Log in

Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 40% of cancer survivors and is associated with functional deficits and an increased falls incidence. There are presently no strongly recommended treatment strategies for CIPN. The aim of this study was to evaluate the impact of a multimodal exercise intervention on CIPN symptoms and related functional deficits, as well as neurophysiologic parameters.

Methods

All outcomes were assessed before and after an 8-week exercise intervention (3-weekly sessions) and preceding 8-week control period at baseline, pre-exercise and post-exercise. Outcome measures were objective and patient-reported CIPN, standing and dynamic balance, mobility, quality of life, and sensory and motor nerve excitability and conduction studies.

Results

Twenty-nine cancer survivors (8 male, 21 female; mean age 61.6 ± 11.8 years) with CIPN symptoms affecting function completed all assessments. Objective and patient-reported CIPN, dynamic balance, standing balance in eyes open conditions, mobility and quality of life were improved from pre- to post-exercise (4.0 < F < 10.2; p < .05), with no changes over the control period (p > .21). No changes were observed in sensory or motor neurophysiologic parameters (p > .23).

Conclusions

This study provides encouraging evidence of the rehabilitative potential of multimodal exercise for persisting CIPN in a post-treatment cohort. Large randomised controlled trials are justified to confirm observed benefits and determine the mechanisms and clinical significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. IARC (2014) (International Agency for Research on Cancer). World Cancer report. In. WHO Press, Geneva

    Google Scholar 

  2. Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63:419–437

    Article  PubMed  Google Scholar 

  3. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. PAIN 155:2461–2470

    Article  PubMed  Google Scholar 

  4. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44:1507–1515

    Article  CAS  Google Scholar 

  5. Mols F, Beijers T, Lemmens V et al (2013) Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 31(21):2699–707

  6. Winters-Stone KM, Horak F, Jacobs PG et al (2017) Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 35(23):2604–2612

  7. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL, American Society of Clinical Oncology (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941–1967

    Article  CAS  PubMed  Google Scholar 

  8. Zimmer P, Trebing S, Timmers-Trebing U et al (2017) Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer:1–10

  9. Kleckner IR, Kamen C, Gewandter JS et al (2017) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer:1–10

  10. Streckmann F, Kneis S, Leifert J et al (2014) Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol 25:493–499

    Article  CAS  PubMed  Google Scholar 

  11. Vollmers PL, Mundhenke C, Maass N, Bauerschlag D, Kratzenstein S, Röcken C, Schmidt T (2018) Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy. J Cancer Res Clin Oncol 144:1785–1792

    Article  PubMed  Google Scholar 

  12. Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B (2016) Interactive sensor-based balance training in older cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology 62:553–563

    Article  PubMed  Google Scholar 

  13. Fernandes J, Kumar S (2016) Effect of lower limb closed kinematic chain exercises on balance in patients with chemotherapy-induced peripheral neuropathy: a pilot study. Int J Rehabil Res 39:368–371

    Article  PubMed  Google Scholar 

  14. Wonders KY, Whisler G, Loy H, Holt B, Bohachek K, Wise R (2013) Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients. Health Psychol Res 1

  15. Streckmann F, Lehmann H, Balke M et al (2018) Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy—a randomized controlled pilot trial. Support Care Cancer:1–8

  16. McCrary JM, Goldstein D, Boyle F et al (2017) Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Support Care Cancer:1–9

  17. Alberti P, Rossi E, Cornblath D et al (2013) Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol 25:257–264

    Article  PubMed  PubMed Central  Google Scholar 

  18. Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377-381

    Google Scholar 

  19. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426

    Article  Google Scholar 

  20. Garnacho-Castaño MV, Domínguez R, González AM et al (2018) Exercise prescription using the Borg rating of perceived exertion to improve fitness. Int J Sports Med 39:115–123

    Article  PubMed  Google Scholar 

  21. Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M (2013) Associations between Borg’s rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol 113:147–155

    Article  PubMed  Google Scholar 

  22. Cornblath D, Chaudhry V, Carter K et al (1999) Total neuropathy score validation and reliability study. Neurology 53:1660–1660

    Article  CAS  PubMed  Google Scholar 

  23. Postma T, Aaronson N, Heimans J, Muller MJ, Hildebrand JG, Delattre JY, Hoang-Xuan K, Lantéri-Minet M, Grant R, Huddart R, Moynihan C, Maher J, Lucey R, EORTC Quality of Life Group (2005) The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41:1135–1139

    Article  CAS  PubMed  Google Scholar 

  24. Mueller MJ, Tuttle LJ, LeMaster JW et al (2013) Weight-bearing versus nonweight-bearing exercise for persons with diabetes and peripheral neuropathy: a randomized controlled trial. Arch Phys Med Rehabil 94:829–838

    Article  Google Scholar 

  25. Sturnieks DL, Arnold R, Lord SR (2011) Validity and reliability of the Swaymeter device for measuring postural sway. BMC Geriatr 11:63

    Article  PubMed  PubMed Central  Google Scholar 

  26. Whitney SL, Wrisley DM, Marchetti GF, Gee MA, Redfern MS, Furman JM (2005) Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the five-times-sit-to-stand test. Phys Ther 85:1034–1045

    PubMed  Google Scholar 

  27. Binda D, Vanhoutte E, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS, CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG (2013) Rasch-built overall disability scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). Eur J Cancer 49:2910–2918

    Article  CAS  PubMed  Google Scholar 

  28. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care:473–483

  29. Kimura J (1983) Electrodiagnosis in diseases of nerve and muscle. F.A. Davis, Philadelphia

    Google Scholar 

  30. Park SB, Goldstein D, Lin CS-Y, Krishnan AV, Friedlander ML, Kiernan MC (2009) Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J Clin Oncol 27:1243–1249

    Article  CAS  PubMed  Google Scholar 

  31. Kiernan MC, Burke D, Andersen KV, Bostock H (2000) Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23:399–409

    Article  CAS  PubMed  Google Scholar 

  32. Pachman DR, Qin R, Seisler D, Smith EML, Kaggal S, Novotny P, Ruddy KJ, Lafky JM, Ta LE, Beutler AS, Wagner-Johnston ND, Staff NP, Grothey A, Dougherty PM, Cavaletti G, Loprinzi CL (2016) Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505). Support Care Cancer 24:5059–5068

    Article  PubMed  PubMed Central  Google Scholar 

  33. Fong DY, Ho JW, Hui BP et al (2012) Physical activity for cancer survivors: meta-analysis of randomised controlled trials. Bmj 344:e70

    Article  PubMed  PubMed Central  Google Scholar 

  34. Gewandter JS, Brell J, Cavaletti G, Dougherty PM, Evans S, Howie L, McDermott MP, O'Mara A, Smith AG, Dastros-Pitei D, Gauthier LR, Haroutounian S, Jarpe M, Katz NP, Loprinzi C, Richardson P, Lavoie-Smith EM, Wen PY, Turk DC, Dworkin RH, Freeman R (2018) Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations. Neurology 91:403–413. https://doi.org/10.1212/WNL.0000000000006083

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J, Sharma NK, Wright DE (2012) The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complicat 26:424–429

    Article  PubMed  PubMed Central  Google Scholar 

  36. Sabatier MJ, Redmon N, Schwartz G, English AW (2008) Treadmill training promotes axon regeneration in injured peripheral nerves. Exp Neurol 211:489–493

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Taube W, Gruber M, Gollhofer A (2008) Spinal and supraspinal adaptations associated with balance training and their functional relevance. Acta Physiol 193:101–116

    Article  CAS  Google Scholar 

  38. Granacher U, Gollhofer A, Strass D (2006) Training induced adaptations in characteristics of postural reflexes in elderly men. Gait & Posture 24:459–466

    Article  CAS  Google Scholar 

  39. Williams RM, Corvo MA, Lam KC et al (2017) Test-retest reliability and practice effects of the stability evaluation test. J Sport Rehabil:1–13

  40. Maurer C, Mergner T, Peterka R (2006) Multisensory control of human upright stance. Exp Brain Res 171:231–250

    Article  CAS  PubMed  Google Scholar 

  41. Greenlee H, Hershman DL, Shi Z et al. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study. JNCI: J Natl Cancer Inst 2017; 109

  42. Lord SR, Clark RD, Webster IW (1991) Physiological factors associated with falls in an elderly population. J Am Geriatr Soc 39:1194–1200

    Article  CAS  PubMed  Google Scholar 

  43. Angst F, Aeschlimann A, Stucki G (2001) Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Care Res 45:384–391

    Article  CAS  Google Scholar 

  44. Goldberg A, Chavis M, Watkins J, Wilson T (2012) The five-times-sit-to-stand test: validity, reliability and detectable change in older females. Aging Clin Exp Res 24:339–344

    Article  PubMed  Google Scholar 

  45. Perera S, Mody SH, Woodman RC, Studenski SA (2006) Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 54:743–749

    Article  PubMed  Google Scholar 

  46. Cormie P, Atkinson M, Bucci L, Cust A, Eakin E, Hayes S, McCarthy S, Murnane A, Patchell S, Adams D (2018) Clinical Oncology Society of Australia position statement on exercise in cancer care. Med J Aust 209:184–187

    Article  Google Scholar 

Download references

Funding

This study was supported by a Cancer Institute NSW Program Grant (14/TPG/1-05) and a National Health and Medical Research Council of Australia (NHMRC) Project Grant (no. 1080521). SBP is supported by a NHMRC Career Development Fellowship (no. 1148595).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanna B. Park.

Ethics declarations

All participants gave their written consent prior to participation. This study was approved by the South Eastern Sydney Local Health District human ethics committee (no. 15-318), performed in accordance with the Declaration of Helsinki, and prospectively registered with the Australian New Zealand Clinical Trials Registry (Trial ID: ACTRN12616000318482).

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McCrary, J.M., Goldstein, D., Sandler, C.X. et al. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy. Support Care Cancer 27, 3849–3857 (2019). https://doi.org/10.1007/s00520-019-04680-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-04680-w

Keywords

Navigation